03
Nov
Nov
According to a single-arm phase 2 clinical trial conducted by the University of Pittsburgh, UPMC Hillman Cancer Center and National Cancer Institute (NCI). Results published in Cancer Cellsupport the development of vidutolimod for the treatment of cutaneous melanoma and provide critical insights that could advance research into this drug for utilize in the treatment of […]